Publicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (9)

2022

  1. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

2021

  1. Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity

    Cardiovascular research, Vol. 117, Núm. 4, pp. 1132-1143

2020

  1. Myocardial function and structure improvement with sacubitril/valsartan in cancer therapy-induced cardiomyopathy

    Revista Espanola de Cardiologia, Vol. 73, Núm. 3, pp. 268-269

2019

  1. Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity

    Journal of the American College of Cardiology, Vol. 73, Núm. 7, pp. 779-791

2017

  1. Dynamic edematous response of the human heart to myocardial infarction: Implications for assessing myocardial area at risk and salvage

    Circulation, Vol. 136, Núm. 14, pp. 1288-1300

  2. Effect of Ischemia Duration and Protective Interventions on the Temporal Dynamics of Tissue Composition after Myocardial Infarction

    Circulation Research, Vol. 121, Núm. 4, pp. 439-450

2016

  1. Patients with calcific aortic stenosis exhibit systemic molecular evidence of ischemia, enhanced coagulation, oxidative stress and impaired cholesterol transport

    International Journal of Cardiology, Vol. 225, pp. 99-106

2010

  1. Respuesta

    Revista Espanola de Cardiologia

2009

  1. Pronóstico y manejo de los pacientes con síndrome coronario agudo y enfermedad polivascular

    Revista Espanola de Cardiologia, Vol. 62, Núm. 9, pp. 1012-1021